Europe Infusion Pumps Market : Share Size, Growth, Industry Share, Forecast And Analysis Report By 2027
The Europe infusion pumps market is
expected to reach US$ 4,969.8 Mn in 2025 from US$ 3,352.4 Mn in 2018. The
market is estimated to grow with a CAGR of 5.8% from 2019-2025.
The growth of the infusion pumps market is primarily attributed to
the rising incidence of diabetes and rising adoption of insulin injection pens
over traditional syringes and vials. However, availability of alternatives for
drug delivery is likely to pose a negative impact on the market growth. On the
other hand, increasing launch of GLP-1 analogues is likely to have a positive
impact on the growth of the Europe infusion pumps market in the coming years.
In recent years, there has been a considerable developments in the
field of medical drug delivery devices. Insulin administration is a common
procedure in diabetic population. Traditional insulin syringes have several
disadvantages that includes experience of pain by patients due to repeated
pricks, discomfort in carrying both insulin bottle as well as syringe, risk of
needle re-use associated infections and needle-stick injuries as well as
difficulty in delivering mixture of two or more liquids together in one
syringe. Additionally, self-administration of insulin through syringes and
vials is time-taking and difficult that has reduced the adoption of these
needles over the past years. On the contrary, pen needles that have emerged as
a solution to combat all the existing issues of the needles and vials for drug
delivery offer several advantages that has led to rapid shift of patients’
preference towards their use. The pre-filled insulin syringes requires minimum
steps of selecting the dose volume and attachment of pen needle which is very
feasible for patients that practice self-administration of insulin on everyday
basis. Moreover, the availability of pen needles in different lengths as well
as gauge sizes provide variety of options to the users to find the best
suitable option according to their needs. According to a research survey
published in Patient Preference and Adherence 2015, approximately 95.2% of
patients participated in the survey that inject insulin regularly found pen
injection method easy to use hassle-free as compared to conventional vial and
syringes use. Thus, owing to above mentioned factors, the market is expected to
grow in the coming years.
Get Sample PDF Of Europe
Infusion Pumps Market @
In 2017, the volumetric pumps segment held a largest market share
of 43.7% of the infusion pumps market, by type. The segment is anticipated to
witness growth at a substantial rate of 6.1% during the forecast period. This
segment is also expected to dominate the market in 2025 owing to its benefits
of delivering monitored dosage of medications to the patient. They are being
preferred highly in hospitals as they are able to deliver large amount of
fluids or medications.
In 2017, the chemotherapy segment held a largest market share of
36.4% of the infusion pumps market, by application. The segment is anticipated
to witness the fastest growth rate of 5.7% during the forecast period. This
segment is also expected to dominate the market in 2025 owing to increases use
of infusion pumps for the administration of medications, to the cancer
patients. The pumps for chemotherapy can be used both for inpatient as well as
outpatient settings, which makes it a preferable choice for cancer patients.
Ask For Discount @
In 2017, the hospital & clinics segment held a largest market
share of 47.5% of the infusion pumps market, by end user. The segment is
anticipated to witness the fastest growth rate of 6.2% during the forecast
period. This segment is also expected to dominate the market in 2025 owing to
rise in the number of surgical procedures as well as reimbursement policies
which make the admission process in hospitals a preferred choice.
Some of the major primary and secondary sources for infusion pumps
included in the report are, Cancer Research Initiatives Foundation (CARIF),
Centers for Disease Control and Prevention (CDC), Clinical Evaluation Report
(CER), Food and Drug Administration (FDA), National Institute for Health and
Care Excellence (NICE) and others.
About Us :
Intelligence Market Research & Consulting, LLP (IMRC) is a
global provider of research reports, business intelligence & consulting
services. We know and understand the importance of market research data for
your institution. Therefore, we have teamed up with the leading research
institutes and strategy specialists to bring to you the latest, niche and most
relevant statistical research.
At IMRC, we have one of the most exhaustive, highly reliable
database of market research reports sourced from publishers and authors after a
thorough quality check and screening of the market study and credentials. We
have a team of key market experts who evaluate the market size, growth
prospects, end-use, applications, value & supply chain and top vendors in
the industry to help the clients to take most accurate and logical business
decisions without any vague assumptions.
Contact
Us:
699, Butler St. Suite 1007
Saugatuck, MI - 49453, United States.
Phone : +1 209
691 5657
Comments
Post a Comment